Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2012
04/19/2012US20120095191 Lh-type bispecific antibody
04/19/2012US20120095188 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094874 Stabilized immunoglobulin constant domains
04/19/2012US20120094873 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
04/19/2012US20120094329 Increasing protein production by increasing abc50 expression or activity
04/19/2012US20120094320 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same
04/19/2012US20120094297 Method For Producing Protein
04/19/2012US20120094294 Bms1 protein expression system
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120093884 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012US20120093855 RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093840 Targeted delivery of factor viii proteins to platelets
04/19/2012US20120093833 Human Oncostatin M Antibodies and Methods of Use
04/19/2012US20120093826 Fully human antibodies specific to cadm1
04/19/2012US20120093825 Method for producing antibody using "naked" expression vector expressing type ii transmembrane fusion protein
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093818 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093805 Anti-cd27 humanized monoclonal antibody
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
04/19/2012CA2814652A1 Human oncostatin m antibodies and methods of use
04/18/2012EP2441846A2 Immunostimulatory combinations of TNFRSF, TLR, NLR, RHR, purinergic receptor, and cytokine receptor agoinsts for vaccines and tumor immunotherapy
04/18/2012EP2441831A1 Process for production of protein
04/18/2012EP1718677B1 Monovalent antibody fragments useful as therapeutics
04/18/2012EP1676860B1 Process for producing antithrombin III composition
04/18/2012EP1005488B9 Receptor that binds trail
04/18/2012EP0894143B2 Vmp-like sequences of pathogenic borrelia
04/18/2012CN1418225B Monoclonal antibodies to the human ldl receptor, their production and use
04/18/2012CN102421913A Ox40/trail fusion proteins
04/18/2012CN102421895A New fungal production system
04/18/2012CN102421799A Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
04/18/2012CN102417920A 一种抗人绒毛促性腺激素单克隆抗体片段的制备方法 A monoclonal antibody against human chorionic gonadotropin preparation fragment
04/18/2012CN102417919A 一种发酵法生产高纯度替考拉宁的方法 Production of high purity teicoplanin method of fermentation
04/18/2012CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha
04/18/2012CN102416195A 胶原蛋白海绵的制备方法 Preparation of collagen sponge
04/18/2012CN101974468B 植物乳杆菌及其应用 Lactobacillus and Its Applications
04/18/2012CN101838621B 枯草芽孢杆菌及脂肽类生物表面活性剂的制备方法 Preparation of Bacillus subtilis and lipopeptide biosurfactants in
04/18/2012CN101736067B 一种乳清蛋白降血压肽及其制备方法与应用 One kind of whey protein antihypertensive peptides and preparation method and application
04/18/2012CN101225371B Preparation technology of recombinant human p43 protein
04/17/2012US8158762 Anti-factor B antibodies and their uses
04/17/2012US8158760 Glycoengineered, recombinant antibody
04/17/2012US8158759 Compositions and methods relating to glucagon receptor antibodies
04/17/2012US8158758 Compositions and methods for treating and diagnosing cancer
04/17/2012US8158757 Compositions and methods for treating and diagnosing cancer
04/17/2012US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/17/2012US8158595 Modular aptamer-regulated ribozymes
04/17/2012US8158581 IGF-1 fusion polypeptides and therapeutic uses thereof
04/17/2012US8158401 Method for isolating and culturing unculturable microorganisms
04/17/2012US8158390 fermentative production of L-valine using coryneform bacteria (e.g. corynebacterium glutamicum), in which transaminase C is modified and/or transaminase C expression is enhanced ; high yield
04/17/2012US8158387 Method for cell surface display of target proteins using FadL of E. coli
04/17/2012US8158386 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
04/17/2012US8158385 Cell death-inducing agent
04/17/2012US8158384 Methods for reducing or eliminating α-mannosidase resistant glycans in the production of glycoproteins
04/17/2012US8158383 Methods of generating protein variants
04/17/2012US8158382 UBP1 protease mutant and its coding sequence, their applications and heterogonous protein expression system
04/17/2012US8158378 Utilizing waste tail gas from a separation unit biogas upgrade systems as beneficial fuel
04/17/2012US8158365 Anti-2-O-desulfated acharan sulfate antibody and its application
04/17/2012US8158132 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence
04/17/2012US8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
04/17/2012US8158130 Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
04/17/2012CA2498636C Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
04/17/2012CA2481521C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/17/2012CA2476425C Ribozymes with broad trna aminoacylation activity
04/17/2012CA2378871C Design of beta-sheet proteins with specific binding properties
04/17/2012CA2225378C Cytokine that induces apoptosis
04/17/2012CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production
04/17/2012CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
04/12/2012WO2012048249A1 Site-specific incorporation of phosphoserine into proteins in escherichia coli
04/12/2012WO2012047732A2 Antibody compositions and methods of use
04/12/2012WO2012047598A1 Methods and compositions for inhibiting viral entry into cells
04/12/2012WO2012047584A2 Macaca fascicularis ccl17
04/12/2012WO2012047583A2 Antibodies binding human collagen ii
04/12/2012WO2012046745A1 Therapeutic agent for malignant tumors expressing mhc class ii
04/12/2012WO2012046731A1 YEAST AND YEAST EXTRACT CONTAINING γ-Glu-Abu, AND METHOD FOR PRODUCING THE YEAST OR YEAST EXTRACT CONTAINING γ-Glu-Abu
04/12/2012WO2012045733A1 Reversibly photoswitchable polypeptides
04/12/2012US20120090039 Immunocompromised Ungulates
04/12/2012US20120088819 Method for enhancing expression of recombinant protein
04/12/2012US20120088729 Non-glycosylated transferrin expressed in monocots
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088717 Method for treating fungal infection with antifungal bifunctional molecules
04/12/2012US20120088695 Method and Device for Protein Delivery into Cells
04/12/2012US20120088272 Methods of generating hybrid/chimeric cells, and uses thereof
04/12/2012US20120088271 Use of an Endogenous 2-Micron Yeast Plasmid for Gene Over Expression
04/12/2012US20120088270 Methods for producing antifungal bifunctional molecules for treating fungal infection
04/12/2012US20120088269 Solution for cell-free protein synthesis, kit for cell-free protein synthesis, and method of protein synthesis
04/12/2012US20120088268 Recombinant production of peptides
04/12/2012US20120088256 Anaplasma translocated substrate-1 (ATS-1) and sero-detection of anaplasma phagocytophilum
04/12/2012US20120088241 Bioreactive Agents
04/12/2012US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
04/12/2012US20120087937 Novel compositions
04/12/2012US20120087932 Diagnostic test for virus
04/12/2012US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies
04/12/2012US20120087927 Antibody containing igg2 having amino acid mutation introduced therein
04/12/2012US20120087923 Antibodies to OPGL
04/12/2012US20120087912 Treatment methods using dkk-1 antibodies